{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T20:55:28Z","timestamp":1791060928423,"version":"4.1.0"},"reference-count":70,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002701","name":"Ministry of Education","doi-asserted-by":"publisher","award":["RS-2025-25431558"],"award-info":[{"award-number":["RS-2025-25431558"]}],"id":[{"id":"10.13039\/501100002701","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014188","name":"Ministry of Science and ICT, South Korea","doi-asserted-by":"publisher","award":["RS-2022-NR070862"],"award-info":[{"award-number":["RS-2022-NR070862"]}],"id":[{"id":"10.13039\/501100014188","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014188","name":"Ministry of Science and ICT, South Korea","doi-asserted-by":"publisher","award":["RS-2025-25442355"],"award-info":[{"award-number":["RS-2025-25442355"]}],"id":[{"id":"10.13039\/501100014188","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014188","name":"Ministry of Science and ICT, South Korea","doi-asserted-by":"publisher","award":["RS-2025-02243112"],"award-info":[{"award-number":["RS-2025-02243112"]}],"id":[{"id":"10.13039\/501100014188","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.bbadis.2026.168177","type":"journal-article","created":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T17:08:05Z","timestamp":1769792885000},"page":"168177","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["HER2-dependent paraptosis and ferroptosis induction by cannabidiol in breast cancer cells"],"prefix":"10.1016","volume":"1872","author":[{"given":"Na Young","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mina","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yejin","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ducdat","family":"Le","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongwoo","family":"Nam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae-Young","family":"Um","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kwang Seok","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbadis.2026.168177_bb0005","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1016\/j.cell.2023.01.040","article-title":"Deciphering breast cancer: from biology to the clinic","volume":"186","author":"Nolan","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.bbadis.2026.168177_bb0010","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.bbadis.2026.168177_bb0015","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1002\/ijc.33588","article-title":"Cancer statistics for the year 2020: an overview","volume":"149","author":"Ferlay","year":"2021","journal-title":"Int. J. Cancer."},{"key":"10.1016\/j.bbadis.2026.168177_bb0020","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/s41572-019-0111-2","article-title":"Breast cancer","volume":"5","author":"Harbeck","year":"2019","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.bbadis.2026.168177_bb0025","doi-asserted-by":"crossref","first-page":"412","DOI":"10.5306\/wjco.v5.i3.412","article-title":"Biological subtypes of breast cancer: prognostic and therapeutic implications","volume":"5","author":"Yersal","year":"2014","journal-title":"World J. Clin. Oncol."},{"key":"10.1016\/j.bbadis.2026.168177_bb0030","series-title":"Breast Cancer, Brisbane (AU)","article-title":"Subtypes of breast cancer","author":"Orrantia-Borunda","year":"2022"},{"key":"10.1016\/j.bbadis.2026.168177_bb0035","doi-asserted-by":"crossref","DOI":"10.3390\/genes15070903","article-title":"A comprehensive review of HER2 in cancer biology and therapeutics","volume":"15","author":"Cheng","year":"2024","journal-title":"Genes (Basel)"},{"key":"10.1016\/j.bbadis.2026.168177_bb0040","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000038508","article-title":"HER2\/PI3K\/AKT pathway in HER2-positive breast cancer: a review","volume":"103","author":"Pan","year":"2024","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.bbadis.2026.168177_bb0045","article-title":"Trastuzumab resistance in HER2-positive breast cancer: mechanisms, emerging biomarkers and targeting agents","volume":"12","author":"Wang","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bbadis.2026.168177_bb0050","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.1016\/S0140-6736(16)32417-5","article-title":"HER2-positive breast cancer","volume":"389","author":"Loibl","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.bbadis.2026.168177_bb0055","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15071987","article-title":"Emerging targeted therapies for HER2-positive breast Cancer","volume":"15","author":"Mercogliano","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.bbadis.2026.168177_bb0060","first-page":"179","article-title":"Targeted lapatinib anti-HER2\/ErbB2 therapy resistance in breast cancer: opportunities to overcome a difficult problem","volume":"3","author":"Wahdan-Alaswad","year":"2020","journal-title":"Cancer Drug Resist"},{"key":"10.1016\/j.bbadis.2026.168177_bb0065","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1093\/annonc\/mdr474","article-title":"Retreatment with trastuzumab-based therapy after disease progression following lapatinib in HER2-positive metastatic breast cancer","volume":"23","author":"Gori","year":"2012","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.bbadis.2026.168177_bb0070","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12113203","article-title":"Cannabidiol (CBD) as a promising anti-Cancer drug","volume":"12","author":"Seltzer","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.bbadis.2026.168177_bb0075","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s11481-015-9608-y","article-title":"The antitumor activity of plant-derived non-psychoactive cannabinoids","volume":"10","author":"McAllister","year":"2015","journal-title":"J. Neuroimmune Pharmacol."},{"key":"10.1016\/j.bbadis.2026.168177_bb0080","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.1365-2125.2012.04298.x","article-title":"Cannabidiol as potential anticancer drug","volume":"75","author":"Massi","year":"2013","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.bbadis.2026.168177_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2024.110995","article-title":"Cannabidiol induces ERK activation and ROS production to promote autophagy and ferroptosis in glioblastoma cells","volume":"394","author":"Kim","year":"2024","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.bbadis.2026.168177_bb0090","doi-asserted-by":"crossref","DOI":"10.1002\/jcb.30537","article-title":"Cannabidiol activates MAPK pathway to induce apoptosis, paraptosis, and autophagy in colorectal cancer cells","volume":"125","author":"Kim","year":"2024","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.bbadis.2026.168177_bb0095","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1158\/1535-7163.MCT-10-1100","article-title":"Cannabidiol induces programmed cell death in breast cancer cells by coordinating the cross-talk between apoptosis and autophagy","volume":"10","author":"Shrivastava","year":"2011","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.bbadis.2026.168177_bb0100","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1111\/cas.16148","article-title":"HER2 mutation as an emerging target in advanced breast cancer","volume":"115","author":"Bon","year":"2024","journal-title":"Cancer Sci."},{"key":"10.1016\/j.bbadis.2026.168177_bb0105","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/s41573-022-00579-0","article-title":"Targeting HER2-positive breast cancer: advances and future directions","volume":"22","author":"Swain","year":"2023","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bbadis.2026.168177_bb0110","doi-asserted-by":"crossref","first-page":"3645","DOI":"10.1158\/0008-5472.CAN-18-0430","article-title":"HER2 amplification in tumors activates PI3K\/Akt signaling independent of HER3","volume":"78","author":"Ruiz-Saenz","year":"2018","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbadis.2026.168177_bb0115","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s10549-009-0502-2","article-title":"HER2 signaling pathway activation and response of breast cancer cells to HER2-targeting agents is dependent strongly on the 3D microenvironment","volume":"122","author":"Weigelt","year":"2010","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.bbadis.2026.168177_bb0120","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djv077","article-title":"Role of cannabinoid receptor CB2 in HER2 pro-oncogenic signaling in breast cancer","volume":"107","author":"Perez-Gomez","year":"2015","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.bbadis.2026.168177_bb0125","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/s41392-024-01769-5","article-title":"Ferroptosis in cancer: from molecular mechanisms to therapeutic strategies","volume":"9","author":"Zhou","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.bbadis.2026.168177_bb0130","article-title":"Paraptosis: a unique cell death mode for targeting cancer","volume":"14","author":"Hanson","year":"2023","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bbadis.2026.168177_bb0135","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/s41401-023-01159-7","article-title":"Paraptosis: a non-classical paradigm of cell death for cancer therapy","volume":"45","author":"Xu","year":"2024","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.bbadis.2026.168177_bb0140","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/s41422-020-00441-1","article-title":"Ferroptosis: molecular mechanisms and health implications","volume":"31","author":"Tang","year":"2021","journal-title":"Cell Res."},{"key":"10.1016\/j.bbadis.2026.168177_bb0145","article-title":"Drug-resistant HER2-positive breast cancer: molecular mechanisms and overcoming strategies","volume":"13","author":"Wu","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bbadis.2026.168177_bb0150","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/s12929-024-01089-4","article-title":"Exploring paraptosis as a therapeutic approach in cancer treatment","volume":"31","author":"Chang","year":"2024","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.bbadis.2026.168177_bb0155","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1038225","article-title":"Inducing ferroptosis has the potential to overcome therapy resistance in breast cancer","volume":"13","author":"Qi","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbadis.2026.168177_bb0160","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.jare.2024.08.033","article-title":"A new 1,2,3-triazole-indirubin hybrid suppresses tumor growth and pulmonary metastasis by mitigating the HGF\/c-MET axis in hepatocellular carcinoma","volume":"73","author":"Gowda","year":"2024","journal-title":"J. Adv. Res."},{"key":"10.1016\/j.bbadis.2026.168177_bb0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2024.102101","article-title":"Oxazine drug-seed induces paraptosis and apoptosis through reactive oxygen species\/JNK pathway in human breast cancer cells","volume":"49","author":"Kim","year":"2024","journal-title":"Transl. Oncol."},{"key":"10.1016\/j.bbadis.2026.168177_bb0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2025.111528","article-title":"Targeting breast cancer cells with 2-indolyl-1,3,4-oxadiazole compounds by inducing apoptosis, paraptosis and autophagy","volume":"415","author":"Uppar","year":"2025","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.bbadis.2026.168177_bb0175","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.biochi.2022.05.018","article-title":"Tanshinone IIA exerts autophagic cell death through down-regulation of beta-catenin in renal cell carcinoma cells","volume":"200","author":"Kim","year":"2022","journal-title":"Biochimie"},{"key":"10.1016\/j.bbadis.2026.168177_bb0180","doi-asserted-by":"crossref","first-page":"6191","DOI":"10.1021\/acsomega.4c11108","article-title":"Cannabinoids as promising inhibitors of HER2-tyrosine kinase: a novel strategy for targeting HER2-positive ovarian Cancer","volume":"10","author":"Lamtha","year":"2025","journal-title":"ACS Omega"},{"key":"10.1016\/j.bbadis.2026.168177_bb0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmcr.2024.100143","article-title":"Identification of potential therapeutic dual inhibitors of EGFR\/HER2 in breast cancer","volume":"11","author":"Jethwa","year":"2024","journal-title":"European Journal of Medicinal Chemistry Reports"},{"key":"10.1016\/j.bbadis.2026.168177_bb0190","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.omtn.2017.12.015","article-title":"Targeting EGFR\/HER2\/HER3 with a three-in-one aptamer-siRNA chimera confers superior activity against HER2(+) breast Cancer","volume":"10","author":"Yu","year":"2018","journal-title":"Mol Ther Nucleic Acids"},{"key":"10.1016\/j.bbadis.2026.168177_bb0195","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1080\/21691401.2017.1326927","article-title":"HER2 positivity may confer resistance to therapy with paclitaxel in breast cancer cell lines","volume":"46","author":"Haghnavaz","year":"2018","journal-title":"Artif. Cells Nanomed. Biotechnol."},{"key":"10.1016\/j.bbadis.2026.168177_bb0200","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1364\/BOE.3.000075","article-title":"Optical imaging of metabolism in HER2 overexpressing breast cancer cells","volume":"3","author":"Walsh","year":"2012","journal-title":"Biomed. Opt. Express"},{"key":"10.1016\/j.bbadis.2026.168177_bb0205","doi-asserted-by":"crossref","DOI":"10.1111\/eci.14174","article-title":"Mitochondrial HER2 stimulates respiration and promotes tumorigenicity","volume":"54","author":"Novotna","year":"2024","journal-title":"Eur. J. Clin. Investig."},{"key":"10.1016\/j.bbadis.2026.168177_bb0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.119954","article-title":"TAD1822-7 induces ROS-mediated apoptosis of HER2 positive breast cancer by decreasing E-cadherin in an EphB4 dependent manner","volume":"285","author":"Zhu","year":"2021","journal-title":"Life Sci."},{"key":"10.1016\/j.bbadis.2026.168177_bb0215","doi-asserted-by":"crossref","first-page":"5811","DOI":"10.18632\/oncotarget.23528","article-title":"Breast cancer stem cells in HER2-negative breast cancer cells contribute to HER2-mediated radioresistance and molecular subtype conversion: clinical implications for serum HER2 in recurrent HER2-negative breast cancer","volume":"9","author":"Kim","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbadis.2026.168177_bb0220","doi-asserted-by":"crossref","first-page":"2713","DOI":"10.3390\/cimb46030171","article-title":"Unveiling the molecular mechanism of Trastuzumab resistance in SKBR3 and BT474 cell lines for HER2 positive breast Cancer","volume":"46","author":"Kokot","year":"2024","journal-title":"Curr. Issues Mol. Biol."},{"key":"10.1016\/j.bbadis.2026.168177_bb0225","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/s41467-019-14111-3","article-title":"Phenotypic changes of HER2-positive breast cancer during and after dual HER2 blockade","volume":"11","author":"Braso-Maristany","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbadis.2026.168177_bb0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbamcr.2022.119344","article-title":"Nimbolide enhances the antitumor effect of docetaxel via abrogation of the NF-kappaB signaling pathway in prostate cancer preclinical models","volume":"1869","author":"Zhang","year":"2022","journal-title":"Biochim. Biophys. Acta, Mol. Cell Res."},{"key":"10.1016\/j.bbadis.2026.168177_bb0235","article-title":"Brassinin induces apoptosis, autophagy, and Paraptosis via MAPK signaling pathway activation in chronic myelogenous leukemia cells","volume":"12","author":"Yang","year":"2023","journal-title":"Biol.-Basel"},{"key":"10.1016\/j.bbadis.2026.168177_bb0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2024.111143","article-title":"Isoxazolyl-urea derivative evokes apoptosis and paraptosis by abrogating the Wnt\/beta-catenin axis in colon cancer cells","volume":"399","author":"Suresh","year":"2024","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.bbadis.2026.168177_bb0245","first-page":"163","article-title":"Upregulation of SOCS2 causes mitochondrial dysfunction and promotes ferroptosis in pancreatic cancer cells","volume":"70","author":"He","year":"2023","journal-title":"Acta Biochim. Pol."},{"key":"10.1016\/j.bbadis.2026.168177_bb0250","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1021\/acsabm.2c00199","article-title":"Ferroptosis-driven Nanotherapeutics to reverse drug resistance in tumor microenvironment","volume":"5","author":"Zhu","year":"2022","journal-title":"ACS Appl. Bio Mater."},{"key":"10.1016\/j.bbadis.2026.168177_bb0255","doi-asserted-by":"crossref","first-page":"4663","DOI":"10.18632\/aging.202518","article-title":"Circular RNA circEPSTI1 accelerates cervical cancer progression via miR-375\/409-3P\/515-5p-SLC7A11 axis","volume":"13","author":"Wu","year":"2021","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.bbadis.2026.168177_bb0260","doi-asserted-by":"crossref","first-page":"6983","DOI":"10.1021\/acsomega.0c00337","article-title":"Amphiphilic cationic Triscyclometalated iridium(III) complex-peptide hybrids induce Paraptosis-like cell death of Cancer cells via an intracellular ca(2+)-dependent pathway","volume":"5","author":"Yokoi","year":"2020","journal-title":"ACS Omega"},{"key":"10.1016\/j.bbadis.2026.168177_bb0265","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","article-title":"Ferroptosis: an iron-dependent form of nonapoptotic cell death","volume":"149","author":"Dixon","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.bbadis.2026.168177_bb0270","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.cell.2017.09.021","article-title":"Ferroptosis: a regulated cell death Nexus linking metabolism, redox biology, and disease","volume":"171","author":"Stockwell","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.bbadis.2026.168177_bb0275","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.109203","article-title":"Small-molecule compounds target paraptosis to improve cancer therapy","volume":"118","author":"Wang","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bbadis.2026.168177_bb0280","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2022.110433","article-title":"Isoimperatorin down-regulates epithelial mesenchymal transition through modulating NF-kappaB signaling and CXCR4 expression in colorectal and hepatocellular carcinoma cells","volume":"99","author":"Kim","year":"2022","journal-title":"Cell. Signal."},{"key":"10.1016\/j.bbadis.2026.168177_bb0285","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s13045-019-0720-y","article-title":"Ferroptosis, a new form of cell death: opportunities and challenges in cancer","volume":"12","author":"Mou","year":"2019","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.bbadis.2026.168177_bb0290","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/nrc2664","article-title":"Targeting PI3K signalling in cancer: opportunities, challenges and limitations","volume":"9","author":"Engelman","year":"2009","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bbadis.2026.168177_bb0295","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/35052073","article-title":"Untangling the ErbB signalling network","volume":"2","author":"Yarden","year":"2001","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.bbadis.2026.168177_bb0300","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23179848","article-title":"Potential application of Leelamine as a novel regulator of chemokine-induced epithelial-to-mesenchymal transition in breast Cancer cells","volume":"23","author":"Jung","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbadis.2026.168177_bb0305","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3892\/ol.2023.14152","article-title":"The inhibitory effect of trastuzumab on BT474 triple-positive breast cancer cell viability is reversed by the combination of progesterone and estradiol","volume":"27","author":"Lopez-Mendez","year":"2024","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.bbadis.2026.168177_bb0310","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1056\/NEJMoa1413513","article-title":"Pertuzumab, trastuzumab, and docetaxel in HER2-positive metastatic breast cancer","volume":"372","author":"Swain","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbadis.2026.168177_bb0315","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2024.101126","article-title":"crVDAC3 alleviates ferroptosis by impeding HSPB1 ubiquitination and confers trastuzumab deruxtecan resistance in HER2-low breast cancer","volume":"77","author":"Zou","year":"2024","journal-title":"Drug Resist. Updat."},{"key":"10.1016\/j.bbadis.2026.168177_bb0320","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1038\/s41467-022-30217-7","article-title":"N6-methyladenosine regulated FGFR4 attenuates ferroptotic cell death in recalcitrant HER2-positive breast cancer","volume":"13","author":"Zou","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbadis.2026.168177_bb0325","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22073680","article-title":"Molecular mechanism of cannabinoids in Cancer progression","volume":"22","author":"Pagano","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbadis.2026.168177_bb0330","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21145064","article-title":"Targeting cannabinoid receptors: current status and prospects of natural products","volume":"21","author":"An","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbadis.2026.168177_bb0335","doi-asserted-by":"crossref","first-page":"5852","DOI":"10.18632\/oncotarget.2233","article-title":"Cannabinoids as therapeutic agents in cancer: current status and future implications","volume":"5","author":"Chakravarti","year":"2014","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbadis.2026.168177_bb0340","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14040885","article-title":"Cannabidiol (CBD) in cancer management","volume":"14","author":"O\u2019Brien","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.bbadis.2026.168177_bb0345","doi-asserted-by":"crossref","first-page":"21960","DOI":"10.1074\/jbc.M114.561761","article-title":"Targeting CB2-GPR55 receptor heteromers modulates cancer cell signaling","volume":"289","author":"Moreno","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2026.168177_bb0350","doi-asserted-by":"crossref","first-page":"6469","DOI":"10.1038\/sj.onc.1210477","article-title":"The oncogene HER2: its signaling and transforming functions and its role in human cancer pathogenesis","volume":"26","author":"Moasser","year":"2007","journal-title":"Oncogene"}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443926000256?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443926000256?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T20:25:19Z","timestamp":1791059119000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0925443926000256"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":70,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S0925443926000256"],"URL":"https:\/\/doi.org\/10.1016\/j.bbadis.2026.168177","relation":{},"ISSN":["0925-4439"],"issn-type":[{"value":"0925-4439","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"HER2-dependent paraptosis and ferroptosis induction by cannabidiol in breast cancer cells","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbadis.2026.168177","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"168177"}}